Insider filing · VKTX
Charles A Rowland Jr
Director
profile →
Viking Therapeutics, Inc.
VKTX · Healthcare · 22 filings in 24 months
ticker →
Charles A Rowland Jr sold $2.1M of Viking Therapeutics (VKTX)
Executed Oct 27 2025, disclosed Oct 28 2025, 1 day later.
Value, as filed
$2.1M
60,000 sh × $35.57
Executed
Oct 27 2025
the trade date, as filed
Disclosed
Oct 28 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CJCharles A Rowland Jr (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $2.1M of VKTX (60,000 sh × $35.57, as filed), executed Oct 27 2025.
The name
VKTXHealthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→